<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>研发客 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-21T07:26:10+08:00</updated>
  <subtitle>《研发客》公众号由上海汐潮信息技术有限公司提供，行业资深中英文独立编辑记者创办。我们观察药物创新生态，报道临床研究与监管科学。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>赛诺菲巴斯德重组四价流感疫苗欧盟获批  力争尽快引进中国 | 新闻稿</title>
    <updated>2020-11-20T21:06:33+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/ZbxqG09zM4sG2cnrNY4DlA</id>
    <link href="https://mp.weixin.qq.com/s/ZbxqG09zM4sG2cnrNY4DlA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>关于“红海”和“蓝海”的思考｜老梁说药</title>
    <updated>2020-11-20T09:33:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/drQoRPisog-jpN8jF3G8CQ</id>
    <link href="https://mp.weixin.qq.com/s/drQoRPisog-jpN8jF3G8CQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲携优秀初创企业  持续加码数字化医疗领域 | 新闻稿</title>
    <updated>2020-11-20T09:33:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/QHYaaoyb_vWXkiuJl2JHkw</id>
    <link href="https://mp.weixin.qq.com/s/QHYaaoyb_vWXkiuJl2JHkw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>德琪医药有限公司于香港联合交易所主板挂牌 | 新闻稿</title>
    <updated>2020-11-20T09:33:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/QaoisseWfcPH6x5PRXhsgA</id>
    <link href="https://mp.weixin.qq.com/s/QaoisseWfcPH6x5PRXhsgA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>辉瑞中国研发中心15周年：多位专家共议研发新突破与新挑战 | 进博会专题</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/9u4eo4PV5eVTGJqnrmExiQ</id>
    <link href="https://mp.weixin.qq.com/s/9u4eo4PV5eVTGJqnrmExiQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球首个皮下注射PD-L1抗体KN035（恩沃利单抗注射液）提交生物制品上市许可申请 | 新闻稿</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/6Zzfthiv4m7CrTCTlFzT5g</id>
    <link href="https://mp.weixin.qq.com/s/6Zzfthiv4m7CrTCTlFzT5g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>11月21日客论直播 ∣ 新法规形势下的国际多中心临床避坑指南</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/QBwTRIkzgDoUU161M3bWjw</id>
    <link href="https://mp.weixin.qq.com/s/QBwTRIkzgDoUU161M3bWjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>水木未来第二届冷冻电镜与药物创新发现论坛 | 会讯</title>
    <updated>2020-11-17T19:55:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/wizCJt3ztT9CHKxupjsaSg</id>
    <link href="https://mp.weixin.qq.com/s/wizCJt3ztT9CHKxupjsaSg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天境生物CD47抗体lemzoparlimab I期数据公布：在实体瘤患者中观察到初步疗效信号 | 第一现场</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Th4Lb6qK7TNva3PZM6GbjA</id>
    <link href="https://mp.weixin.qq.com/s/Th4Lb6qK7TNva3PZM6GbjA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1类创新化药贺普拉肽治疗慢性乙肝Ⅱ期临床试验启动 | 新闻稿</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/EXCWO4XGRJ1H_G5uGlQk2w</id>
    <link href="https://mp.weixin.qq.com/s/EXCWO4XGRJ1H_G5uGlQk2w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020中国肿瘤学大会：聚焦新疗法与新理念 | 新闻稿</title>
    <updated>2020-11-16T22:43:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Dk-n2lKwoLGl_fg6No-kSQ</id>
    <link href="https://mp.weixin.qq.com/s/Dk-n2lKwoLGl_fg6No-kSQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>探索中国创新药企的专科之路｜遇见潘柯</title>
    <updated>2020-11-15T22:39:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/ezEFfVgKl4XrQc9O3L8R7g</id>
    <link href="https://mp.weixin.qq.com/s/ezEFfVgKl4XrQc9O3L8R7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>陈思渊：希望尽快将我们的创新产品引入中国 | 进博会专题</title>
    <updated>2020-11-13T21:44:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/RKEfMxO4bF281hu93rY0cw</id>
    <link href="https://mp.weixin.qq.com/s/RKEfMxO4bF281hu93rY0cw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Tavotek：创新有序, 用技术之手突破成药障碍 | 江湖</title>
    <updated>2020-11-13T21:44:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/BfHrU0rxZVB9MTtZQzBnUQ</id>
    <link href="https://mp.weixin.qq.com/s/BfHrU0rxZVB9MTtZQzBnUQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺和诺德黑科技——胰岛素发现100年再畅想 | 光影 · 世界糖尿病日专题</title>
    <updated>2020-11-12T22:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/Qtq9Q4SJTpiq96r3lg3HSA</id>
    <link href="https://mp.weixin.qq.com/s/Qtq9Q4SJTpiq96r3lg3HSA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>诺和诺德在进博会宣布“中国同创”2.0计划    助力中国跻身全球医药创新第一梯队 | 新闻稿</title>
    <updated>2020-11-12T22:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/KupBfPKLhWAMemeexEvIDw</id>
    <link href="https://mp.weixin.qq.com/s/KupBfPKLhWAMemeexEvIDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BiG巨献：三大院士、四门论坛、六十大咖、五百盛会！| 会议</title>
    <updated>2020-11-12T22:28:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/nREo13mscGGDKCJRlv1VJw</id>
    <link href="https://mp.weixin.qq.com/s/nREo13mscGGDKCJRlv1VJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>与华西、湘雅达成战略合作  礼来全力参与中国临床研究生态建设 | 进博会专题</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/c6BhbJbzvkdz1Eye97cJ1g</id>
    <link href="https://mp.weixin.qq.com/s/c6BhbJbzvkdz1Eye97cJ1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>晶泰科技与华东医药签署合作协议，AI将参与又一款抗肿瘤新药研发 | 新闻稿</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/gL3Aa9Ic07O0EHitM5aJtA</id>
    <link href="https://mp.weixin.qq.com/s/gL3Aa9Ic07O0EHitM5aJtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>天境生物在2020年SITC年会上公布肿瘤免疫新靶点抗体TJ210/MOR210临床前数据 | 新闻稿</title>
    <updated>2020-11-11T20:49:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/2lMGEn0JVU7XJ4XHTXz3Iw</id>
    <link href="https://mp.weixin.qq.com/s/2lMGEn0JVU7XJ4XHTXz3Iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>